(Q41667017)

6 October 2017

1 reference

title

Carnitine and its derivatives in cardiovascular disease (English)

1 reference

6 October 2017

main subject

cardiovascular disease

1 reference

Arsenian MA

1

1 reference

6 October 2017

publication date

1 November 1997

1 reference

Progress in Cardiovascular Diseases

6 October 2017

published in

1 reference

6 October 2017

volume

40

1 reference

6 October 2017

issue

3

1 reference

6 October 2017

page(s)

265-286

1 reference

Action of carnitine on long chain fatty acid oxidation by liver

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Influence of carnitine supplementation on muscle substrate and carnitine metabolism during exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Acetyl-L-carnitine treatment increases nerve growth factor levels and choline acetyltransferase activity in the central nervous system of aged rats

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Protection against lethal ammonia intoxication: synergism between endogenous ornithine and L-carnitine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effect of acetyl-L-carnitine on recovery of brain phosphorus metabolites and lactic acid level during reperfusion after cerebral ischemia in the rat--study by 13P- and 1H-NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

L-carnitine as a treatment of lethargy in children with chronic neurologic handicaps

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Carnitine depletion in peripheral blood mononuclear cells from patients with AIDS: effect of oral L-carnitine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effects of carnitine isomers on fatty acid metabolism in ischemic swine hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Protection of the ischaemic myocardium by L-propionylcarnitine: effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Metabolic and physiological differences between zero-flow and low-flow myocardial ischemia: effects of L-acetylcarnitine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Anaplerotic effect of propionyl carnitine in rat heart mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Protective effects of propionyl-L-carnitine during ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Lack of correlation between the antiarrhythmic effect of L-propionylcarnitine on reoxygenation-induced arrhythmias and its electrophysiological properties

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Antiradical effects in L-propionyl carnitine protection of the heart against ischemia-reperfusion injury: the possible role of iron chelation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Propionyl-L-carnitine: biochemical significance and possible role in cardiac metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

The efflux of L-carnitine from cells in culture (CCL 27).

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

The myocardial distribution and plasma concentration of carnitine in patients with mitral valve disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Myocardial carnitine in end-stage congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

1 reference

7 January 2021

Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Carnitine metabolism in human subjects II. Values of carnitine in biological fluids and tissues of “normal” subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Metabolic fate of dietary carnitine in human adults: identification and quantification of urinary and fecal metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

The reconstituted carnitine carrier from rat liver mitochondria: evidence for a transport mechanism different from that of the other mitochondrial translocators

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Carnitine--metabolism and functions

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Pharmacokinetics and safety of l-carnitine infused i.v. in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effect of exogenous carnitine on carnitine homeostasis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effect of intravenous L-carnitine on carnitine homeostasis and fuel metabolism during exercise in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Changes in tissue levels of carnitine and other metabolites during myocardial ischemia and anoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Role of carnitine in fatty acid metabolism of normal and ischemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Subcellular distribution of endogenous long chain acylcarnitines during hypoxia in adult canine myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Cellular uncoupling induced by accumulation of long-chain acylcarnitine during ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Inhibition of (Na++K+)-stimulated ATPase of heart by fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Inhibition of sodium pump by l-palmitoylcarnitine in single guinea-pig ventricular myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Differential mechanism of block of palmitoyl lysophosphatidylcholine and of palmitoylcarnitine on inward rectifier K+ channels of guinea-pig ventricular myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effects of some L-carnitine derivatives on heart membrane ATPases

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Palmitylcarnitine inhibition of the calcium pump in cardiac sarcoplasmic reticulum: A possible role in myocardial ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Acyl-CoA inhibition of adenine nucleotide translocation in ischemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Inhibition of the mitochondrial adenine nucleotide transport system by oleyl CoA.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effects of glucose-insulin-potassium solution on free fatty acid metabolism in ischemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Palmitoyl-L-carnitine modifies the function of vascular endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Interactions of palmitoyl carnitine with the endothelium in rat aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Ischemic preconditioning and long-chain acyl carnitine in the canine heart

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

The effect of propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effects of L-carnitine on ventricular arrhythmias after coronary reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effects of L-carnitine on tissue levels of acyl carnitine, acyl coenzyme A and high energy phosphate in ischemic dog hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effect of L-carnitine on mitochondrial acyl CoA esters in the ischemic dog heart

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Protection of the ischemic dog myocardium with carnitine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effects of L-carnitine on phospholipids in the ischemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Glucose oxidation is stimulated in reperfused ischemic hearts with the carnitine palmitoyltransferase 1 inhibitor, Etomoxir

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Plasma fatty acid levels in infants and adults after myocardial ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow in acutely and chronically diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Protection of the ischemic diabetic heart by L-propionylcarnitine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effect of aging and acetyl-L-carnitine on the activity of cytochrome oxidase and adenine nucleotide translocase in rat heart mitochondria.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Beneficial effect of carnitine on mechanical recovery of rat hearts reperfused after a transient period of global ischemia is accompanied by a stimulation of glucose oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effects of L-carnitine on the pyruvate dehydrogenase complex and carnitine palmitoyl transferase activities in muscle of endurance athletes

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Free radical scavenging is involved in the protective effect of L-propionyl-carnitine against ischemia-reperfusion injury of the heart.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Biochemical and morphologic correlates of cardiac ischemia. I. Membrane systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Improvement of myocardial function in diabetic rats after treatment with L-carnitine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Carnitine distribution in subepicardial and subendocardial regions in normal and ischemic dog hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effects of excess free fatty acids on mechanical and metabolic function in normal and ischemic myocardium in swine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

MYOCARDIAL CARNITINE DEFICIENCY IN ACUTE MYOCARDIAL INFARCTION

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Carnitine levels in human serum in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

The effect of L-carnitine on myocardial protection in cold cardioplegia followed by reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Control of the cardiac consequences of myocardial ischemia and reperfusion by L-propionylcarnitine: age-response and dose-response studies in the rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effect of propionyl-L-carnitine on experimental myocardial infarction in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effects of Carnitine in Ischemic and Fatty Acid Supplemented Swine Hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Protection of the reperfused heart by L-propionylcarnitine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

High doses of L-carnitine in acute myocardial infarction: metabolic and antiarrhythmic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Improved pacing tolerance of the ischemic human myocardium after administration of carnitine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

The metabolical effects of L-carnitine in angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effects of L-propionylcarnitine on ischemia-induced myocardial dysfunction in men with angina pectoris.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effects of L-carnitine on exercise tolerance in patients with stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Propionyl carnitine in stable effort angina

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Metabolic effects of propionate, hexanoate and propionylcarnitine in normoxia, ischaemia and reperfusion. Does an anaplerotic substrate protect the ischaemic myocardium?

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

L-propionylcarnitine does not affect myocardial metabolic or functional response to chronotropic and inotropic stimulation after repetitive ischemia in anesthetized pigs.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Delineation of the influence of propionylcarnitine on the accumulation of long-chain acylcarnitines and electrophysiologic derangements evoked by hypoxia in canine myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effects of carnitine on the ischemic arrested heart

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Protection of the Myocardium during Ischemic Arrest: Possible Toxicity of Carnitine in Cardioplegic Solutions*

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Cardioprotective effects of carnitine in extensive aortocoronary bypass grafting: a double-blind, randomized, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Safety, tolerability, and efficacy of a glucose-insulin-potassium-magnesium-carnitine solution in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Carnitine-induced effects on cardiac and peripheral hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effect of L-Carnitine on cardiac hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effects of L-carnitine loading on the aerobic and anaerobic performance of endurance athletes.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Short-term hemodynamic effects of intravenous propionyl-L-carnitine in anesthetized dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effect of propionyl-L-carnitine on mechanical function of isolated rabbit heart

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Functional and metabolic effects of propionyl-L-carnitine in the isolated perfused hypertrophied rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Hemodynamic study of intravenous propionyl-L-carnitine in patients with ischemic heart disease and normal left ventricular function.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Carnitine delays rat skeletal muscle fatigue in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Respiratory chain enzymes in muscle of endurance athletes: effect of L-carnitine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Influence of L-carnitine administration on maximal physical exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

The effect of oral supplementation with L-carnitine on maximum and submaximum exercise capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

The effect of marathon running on carnitine metabolism and on some aspects of muscle mitochondrial activities and antioxidant mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Electrophysiologic evaluation of intravenous L-propionylcarnitine in man

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Anti-arrhythmic effects of (-)-carnitine chloride and its acetyl analogue on canine late ventricular arrhythmia induced by ligation of the coronary artery as related to improvement of mitochondrial function

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Protective effects of D,L-carnitine against arrhythmias induced by lysophosphatidylcholine or reperfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effects of L-carnitine on arrhythmias during hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Cardiac manifestations in disorders of fat and carnitine metabolism in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Carnitine deficiency presenting as familial cardiomyopathy: a treatable defect in carnitine transport

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Four-year treatment of systemic carnitine deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Defective myocardial carnitine metabolism in congestive heart failure secondary to dilated cardiomyopathy and to coronary, hypertensive and valvular heart diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Plasma carnitine concentrations in cardiomyopathy patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Urinary carnitine excretion in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

L-carnitine treatment for congestive heart failure--experimental and clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Cardiac carnitine deficiency and altered carnitine transport in cardiomyopathic hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Myocardial carnitine deficiency in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Free fatty acid oxidation and carnitine levels in diphtheritic guinea pig myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

L-carnitine treatment improves cardiac performance and restores high-energy phosphate pools in cardiomyopathic Syrian hamster

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Assessment of the cardiostimulant action of propionyl-L-carnitine on chronically volume-overloaded rat hearts.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effect of L-carnitine treatment on lipid metabolism and cardiac performance in chronically diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effect of short- and long-term diabetes on carnitine and myo-inositol in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Changes in the subcellular distribution of free carnitine and its acyl derivatives in diabetic rat hearts following treatment with L-carnitine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Salient effects of L-carnitine on adenine-nucleotide loss and coenzyme A acylation in the diabetic heart perfused with excess palmitic acid. A phosphorus-31 NMR and chemical extract study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

In vivo and in vitro intervention with L-carnitine prevents abnormal energy metabolism in isolated diabetic rat heart: chemical and phosphorus-31 NMR evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Changes of lipid concentrations in liver and serum by administration of carnitine added diets in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

L-carnitine effect on plasma lipoproteins of hyperlipidemic fat-loaded rats

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

The effect of exogenous L-carnitine on fat diet-induced hyperlipidemia in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Pharmacologic action of L-carnitine on hypertriglyceridemia in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Propionyl-L-carnitine prevents the progression of atherosclerotic lesions in aged hyperlipemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Lipid-lowering effect of carnitine in patients with type-IV hyperlipoproteinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

L-carnitine and platelet aggregation in uremic patients subjected to hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Carnitine abnormalities in patients with renal insufficiency. Pathophysiological and therapeutical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Carnitine improves lipid anomalies in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

The effect of L-carnitine on cholesterol metabolism in rat (Rattus bubalus) hepatocyte cells

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Carnitine metabolism during exercise in patients with peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Carnitine metabolism during prolonged exercise and recovery in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Increased acetyl carnitine in rat skeletal muscle as a result of high-intensity short-duration exercise. Implications in the control of pyruvate dehydrogenase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Benefit of exercise conditioning for patients with peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Muscle carnitine deficiency in patients with severe peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effect of propionyl-L-carnitine in a rat model of peripheral arteriopathy: A functional, histologic, and NMR spectroscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effect of L-carnitine on the reactive hyperemia in patients affected by peripheral vascular disease: a double-blind, crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Propionyl-l-carnitine in intermittent claudication: Double-blind, placebo-controlled, dose titration, multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

L-carnitine supplementation in humans. The effects on physical performance

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

Effect of L-Carnitine on the Cellular Distribution of Carnitine and Its Acyl Derivatives in the Ischemic Heart

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2897%2980037-0

7 January 2021

10.1016/S0033-0620(97)80037-0

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mygqn5gjhfg3jkwnnm57tm4pvy

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_mygqn5gjhfg3jkwnnm57tm4pvy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mygqn5gjhfg3jkwnnm57tm4pvy

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/mygqn5gjhfg3jkwnnm57tm4pvy

1 reference

30 July 2022